ATMUMEDIUM SIGNALFINANCIAL10-K

ATMU delivered solid operational performance with substantially higher operating cash flow generation and balanced growth across key financial metrics.

The company demonstrated strong cash conversion capabilities with operating cash flow nearly doubling year-over-year, indicating improved working capital management and operational efficiency. The balanced growth in revenues, margins, and balance sheet strength suggests ATMU is executing well on its filtration business strategy while maintaining financial discipline.

Comparing 2026-02-13 vs 2025-02-21View on EDGAR →
FINANCIAL ANALYSIS

ATMU showed broad-based financial improvement with net sales growing to $1.76 billion, operating income expanding 12% to $299 million, and net income rising 12% to $207 million. The most notable performance came from cash generation, with operating cash flow substantially higher at $203 million compared to $105 million in the prior year. Balance sheet metrics strengthened across the board, with stockholders' equity growing 66% to $379 million and total assets expanding 14% to $1.4 billion, reflecting a company building financial resilience while investing for growth.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
+92.3%
$105.4M$202.7M

Operating cash flow surged 92.3% — exceptional cash generation, highest quality earnings signal.

Stockholders Equity
Balance Sheet
+66.4%
$227.4M$378.5M

Equity base grew 66.4% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Cash & Equivalents
Balance Sheet
+28.3%
$184.3M$236.4M

Cash grew 28.3% — improving liquidity position supports investment and shareholder returns.

Accounts Receivable
Balance Sheet
+25.9%
$254.2M$320.1M

Receivables grew 25.9% — monitor days sales outstanding for collection efficiency.

Current Assets
Balance Sheet
+18.2%
$755.0M$892.4M

Current assets grew 18.2% — improving short-term liquidity or inventory/receivables build.

Total Assets
Balance Sheet
+13.5%
$1.2B$1.4B

Asset base grew 13.5% — expansion through organic growth, acquisitions, or capital deployment.

Operating Income
P&L
+12.3%
$266.2M$299.0M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

Net Income
P&L
+11.7%
$185.6M$207.4M

Net income grew 11.7% — bottom-line growth signals improving overall business health.

LANGUAGE CHANGES
NEW — 2026-02-13
PRIOR — 2025-02-21
ADDED
As of January 31, 2026, 81,508,591 shares of the registrant s common stock, par value $0.0001 per share, were outstanding.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 83 Item 9A.
For the year ended December 31, 2025 , Atmus generated $1,764.3 million in Net sales, $207.4 million in Net income and $353.5 million in Adjusted EBITDA.
Atmus Global Footprint Atmus serves end-users globally, with approximately 46% of its Net sales in 2025 from outside of the United States and Canada.
Atmus has a broad IP portfolio with approximately 1,200 worldwide active or pending patents and patent applications and over 650 worldwide trademark registrations and applications as of December 31, 2025.
+7 more — sign up free →
REMOVED
As of January 31, 2025, 82,866,170 shares of the registrant s common stock, par value $0.0001 per share, were outstanding.
Changes in and Disagreements W ith Accountants on Accounting and Financial Disclosure 86 Item 9A.
For the year ended December 31, 2024, Atmus generated $1,669.6 million in Net sales, $185.6 million in Net income and $329.5 million in Adjusted EBITDA.
Atmus Global Footprint Atmus serves end-users globally, with approximately 48% of its Net sales in 2024 from outside of the United States and Canada.
Atmus has leveraged this expertise not only to develop its cutting-edge filters, filter systems and filtration media but also to manufacture a large portion of its proprietary filtration media.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →